```html

Neonatal Sepsis – A Complete Medical Guide

Overview

Neonatal sepsis is a life‑threatening systemic infection that occurs in infants ≤ 28 days of life. It can develop within the first 72 hours after birth (early‑onset sepsis, EOS) or after that period (late‑onset sepsis, LOS). The infection can involve bacteria, fungi, or viruses, but bacterial pathogens account for the majority of cases.

Who is affected? All newborns are vulnerable, but the risk is highest in:

• Preterm infants (<37 weeks gestation)
• Very low birth‑weight babies (<1500 g)
• Infants born to mothers with intra‑amniotic infection, prolonged rupture of membranes, or Group B Streptococcus (GBS) colonization
• Newborns requiring invasive devices (e.g., central lines, endotracheal tubes)

Prevalence varies worldwide. In high‑income countries, the incidence of EOS ranges from 0.5–1.0 per 1,000 live births, while LOS occurs in roughly 2–4 % of NICU patients. In low‑ and middle‑income settings, rates can be as high as 5–10 % of all newborns, accounting for up to 30 % of neonatal deaths <sup>1</sup>. Early recognition and treatment dramatically improve outcomes.

Symptoms

Neonatal sepsis presents with nonspecific signs that can mimic other conditions. A high index of suspicion is essential.

General / Systemic Signs

• Temperature instability: fever (>38 °C) or hypothermia (<36 °C)
• Lethargy or irritability: reduced feeding, excessive crying, or lack of response to stimuli
• Tachypnea: respiratory rate >60 breaths/min
• Tachycardia or bradycardia: HR >180 bpm or <100 bpm
• Apnea: pause in breathing lasting >20 seconds
• Hypotension: systolic BP <30 mm Hg (preterm) or <60 mm Hg (term)
• Jaundice: yellowing of skin/eyes not explained by physiologic bilirubin rise

Respiratory Signs

• Grunting, nasal flaring, or chest retractions
• Oxygen desaturation (SpO₂ <90 %)
• Congestive heart failure signs – pulmonary edema

Gastrointestinal / Metabolic Signs

• Vomiting or bilious emesis
• Abdominal distention
• Diarrhea or abnormal stools
• Metabolic acidosis (low HCO₃⁻, high lactate)

Dermatologic Signs

• Petechiae or purpura (especially in meningococcal infection)
• Erythematous maculopapular rash
• Umbilical erythema or cellulitis

Causes and Risk Factors

Primary Pathogens

• Group B Streptococcus (GBS): leading cause of EOS in many countries
• Escherichia coli: especially in preterm infants
• Klebsiella pneumoniae, Staphylococcus aureus, Coagulase‑negative Staphylococci (CoNS): common in LOS
• Fungal organisms: Candida spp. in very low birth‑weight infants

Risk Factors

• Maternal Factors: GBS colonization, chorioamnionitis, urinary tract infection, intrapartum fever, prolonged rupture of membranes (>18 h)
• Delivery‑Related: preterm labor, low Apgar score, need for resuscitation, use of invasive monitoring
• Neonatal Factors: prematurity, low birth weight, congenital anomalies, need for central venous catheters, prolonged NICU stay, prior antibiotic exposure
• Environmental: crowded NICU units, limited infection‑control practices

Diagnosis

Because clinical signs are subtle, a combination of laboratory testing and clinical assessment is required.

Initial Clinical Evaluation

• Full physical exam focusing on perfusion, respiratory effort, skin, and neurologic status
• Maternal and obstetric history to assess EOS risk

Laboratory Tests

• Blood cultures: gold standard; obtain before antibiotics if possible (≥1 mL per bottle for term, 0.5 mL for preterm)
• Complete blood count (CBC) with differential: neutropenia or neutrophilia, immature‑to‑total neutrophil ratio (I/T) >0.2 suggests infection
• C‑reactive protein (CRP): rises within 6–12 h; serial measurements improve sensitivity
• Procalcitonin (PCT): more specific for bacterial sepsis; peaks at 12–24 h
• Lumbar puncture: indicated if meningitis is suspected; CSF analysis and culture
• Urine culture: obtained via catheterization or suprapubic aspiration
• Chest radiograph: evaluates for pneumonia or effusions

Advanced Diagnostics

• Polymerase chain reaction (PCR) panels: rapid detection of bacterial DNA, useful for GBS and E. coli
• Whole‑genome sequencing (WGS): emerging tool in NICU outbreaks

Treatment Options

Empiric Antibiotic Therapy

Begin within 1 hour of suspicion to reduce mortality.

• Early‑Onset Sepsis (EOS):
  • ≥ 37 weeks: ampicillin + gentamicin
  • <37 weeks or high risk for resistant organisms: ampicillin + gentamicin + cefotaxime
• Late‑Onset Sepsis (LOS):
  • Coagulase‑negative Staphylococci: vancomycin ± gentamicin
  • Gram‑negative rods: cefepime or meropenem ± gentamicin

Therapy is adjusted once culture results and sensitivities are available (typically 48–72 h). Duration is usually 10–14 days for uncomplicated bacteremia, longer for meningitis or deep‑tissue infection.

Supportive Care

• Thermoregulation – maintain normothermia (36.5–37.5 °C)
• Fluid resuscitation – isotonic saline boluses (10 mL/kg) for hypotension
• Vasopressors (dopamine, norepinephrine) if refractory shock
• Ventilatory support – CPAP or mechanical ventilation as needed
• Blood product transfusion for severe anemia or coagulopathy

Antifungal Therapy (if indicated)

For confirmed or high‑risk Candida infection: fluconazole (first line) or amphotericin B for resistant strains.

Adjunctive Measures

• Peripheral or central line removal if it is the suspected source
• Intravenous immunoglobulin (IVIG) – reserved for selected cases with hypogammaglobulinemia
• Granulocyte transfusion – considered in profound neutropenia with refractory infection

Lifestyle & Home‑care Adjustments (post‑discharge)

• Strict hand‑hygiene for caregivers
• Continue any prescribed antibiotics for the full course
• Follow‑up blood work to ensure resolution of inflammatory markers
• Monitor growth and neurodevelopment milestones

Living with Neonatal Sepsis

Hospital Stay

Most affected infants require NICU admission. Families should be encouraged to participate in care (kangaroo‑care, breastfeeding support) as early as the infant’s condition permits.

Feeding

• Prefer breast milk – it contains antibodies and reduces future infection risk
• If breast milk unavailable, use sterile, fortified formula per NICU protocol
• Gradual advancement of feeds once hemodynamically stable

Neuro‑developmental Surveillance

Sepsis, especially when prolonged, can affect the developing brain. Schedule early intervention services, audiology, and vision screening.

Parental Support

• Psychosocial counseling – parental anxiety and depression are common
• Connect with support groups (e.g., March of Dimes, local NICU families groups)
• Provide clear discharge instructions and a 24‑hour contact line for concerns

Prevention

• Maternal Screening: Universal GBS culture at 35–37 weeks; intrapartum antibiotics for positive results (penicillin or ampicillin) <sup>2</sup>.
• Intrapartum Antibiotic Prophylaxis (IAP): Reduces EOS by 80 % when administered >4 h before delivery.
• Strict Hand Hygiene & Aseptic Technique: Alcohol‑based rubs, sterile insertion of lines, and barrier precautions in NICU.
• Limiting Invasive Devices: Early removal of central lines and urinary catheters when no longer needed.
• Breastfeeding Promotion: Early lactation support decreases LOS incidence.
• Vaccination of Household Contacts: Influenza and pertussis vaccinations protect vulnerable newborns.
• Environmental Controls: Cohorting of colonized infants, regular cleaning of equipment.

Complications

If not recognized and treated promptly, neonatal sepsis can lead to:

• Septic shock – multi‑organ failure, high mortality
• Disseminated intravascular coagulation (DIC)
• Acute respiratory distress syndrome (ARDS)
• Persistent pulmonary hypertension
• Necrotizing enterocolitis (NEC)
• Meningitis – risk of hydrocephalus, cerebral palsy, hearing loss
• Renal failure
• Long‑term neurodevelopmental impairment – learning difficulties, motor delays

Overall neonatal sepsis mortality ranges from 5–20 % in high‑resource settings and up to 50 % in low‑resource environments <sup>3</sup>.

When to Seek Emergency Care

---

Sources:

1. Mayo Clinic. “Neonatal sepsis.” Accessed March 2024.
2. CDC. “Prevention of Perinatal Group B Streptococcal Disease.” Updated 2023.
3. World Health Organization. “Neonatal sepsis: burden, prevention and management.” 2022.
4. Cleveland Clinic. “Management of Neonatal Sepsis.” 2023.
5. NIH National Institute of Child Health and Human Development. “Neonatal Infections.” 2024.

```